Related references
Note: Only part of the references are listed.Arrested Oocyst Maturation in Plasmodium Parasites Lacking Type II NADH:Ubiquinone Dehydrogenase
Katja E. Boysen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Two internal type II NADH dehydrogenases of Toxoplasma gondii are both required for optimal tachyzoite growth
San San Lin et al.
MOLECULAR MICROBIOLOGY (2011)
Ascochlorin is a novel, specific inhibitor of the mitochondrial cytochrome bc1 complex
Edward A. Berry et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2010)
Inhibiting Plasmodium cytochrome bc1: a complex issue
Victoria Barton et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
SYNTHESIS OF NOVEL 1-HYDROXYQUINOLONES WITH HIGH ANTI-TOXOPLASMA ACTIVITY
Lutz F. Tietze et al.
HETEROCYCLES (2010)
CRIMALDDI: a co-ordinated, rational, and integrated effort to set logical priorities in anti-malarial drug discovery initiatives
Ian C. Boulton et al.
MALARIA JOURNAL (2010)
Type II NADH dehydrogenase of the respiratory chain of Plasmodium falciparum and its inhibitors
Carolyn K. Dong et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Type II NADH Dehydrogenase Inhibitor 1-Hydroxy-2-Dodecyl-4(1H) Quinolone Leads to Collapse of Mitochondrial Inner-Membrane Potential and ATP Depletion in Toxoplasma gondii
San San Lin et al.
EUKARYOTIC CELL (2009)
The Toxoplasma gondii type-II NADH dehydrogenase TgNDH2-I is inhibited by 1-hydroxy-2-alkyl-4(1H)quinolones
San San Lin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2008)
Molecular basis of resistance to cytochrome bc(1) inhibitors
Nick Fisher et al.
FEMS YEAST RESEARCH (2008)
Structure of complex III with bound cytochrome c in reduced state and definition of a minimal core interface for electron transfer
Sozanne R. N. Solmaz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Acridinediones:: Selective and potent inhibitors of the malaria parasite mitochondrial bc1 complex
Giancarlo A. Biagini et al.
MOLECULAR PHARMACOLOGY (2008)
Network pharmacology: the next paradigm in drug discovery
Andrew L. Hopkins
NATURE CHEMICAL BIOLOGY (2008)
The malaria parasite type IINADH:quinone oxidoreductase:: an alternative enzyme for an alternative lifestyle
Nicholas Fisher et al.
TRENDS IN PARASITOLOGY (2007)
Growth inhibition of Toxoplasma gondii and Plasmodium falciparum by nanomolar concentrations of 1-hydroxy-2-dodecyl-4(1H)quinolone, a high-affinity inhibitor of alternative (type II) NADH dehydrogenases
Ahmad Saleh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum
Heather J. Painter et al.
NATURE (2007)
Investigating the Qn site of the cytochrome bc1 complex in Saccharomyces cerevisiae with mutants resistant to ilicicolin H, a novel Qn site inhibitor
Martina G. Ding et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Prevalence of Plasmodium falciparum cytochrome b gene mutations in isolates imported from Africa, and implications for atovaquone resistance
A. Berry et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2006)
Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations
Lise Musset et al.
MICROBES AND INFECTION (2006)
Functional characterization and target validation of alternative complex I of Plasmodium falciparum mitochondria
GA Biagini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Re-examination of inhibitor resistance conferred by Qo-site mutations in cytochrome b using yeast as a model system
N Fisher et al.
PEST MANAGEMENT SCIENCE (2005)
Binding of the respiratory chain inhibitor antimycin to the mitochondrial bc1 complex:: A new crystal structure reveals an altered intramolecular hydrogen-bonding pattern
LS Huang et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Cytochrome b mutations that modify the ubiquinol-binding pocket of the cytochrome bc1 complex and confer anti-malarial drug resistance in Saccharomyces cerevisiae
JJ Kessl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
HDQ (1-hydroxy-2-dodecyl-4(1H)quinolone), a high affinity inhibitor for mitochondrial alternative NADH dehydrogenase
A Eschemann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Human disease-related mutations in cytochrome b studied in yeast
N Fisher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Crystallographic studies of quinol oxidation site inhibitors:: A modified classification of inhibitors for the cytochrome bc1 complex
L Esser et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening
M Smilkstein et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Improved protein-ligand docking using GOLD
ML Verdonk et al.
PROTEINS-STRUCTURE FUNCTION AND GENETICS (2003)
Recapitulation in Saccharomyces cerevisiae of cytochrome b mutations conferring resistance to atovaquone in Pneumocystis jiroveci
P Hill et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Structural basis for the quinone reduction in the bc1 complex:: A comparative analysis of crystal structures of mitochondrial cytochrome bc1 with bound substrate and inhibitors at the Qi site
XG Gao et al.
BIOCHEMISTRY (2003)
Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa
E Schwartz et al.
CLINICAL INFECTIOUS DISEASES (2003)
Protonmotive pathways and mechanisms in the cytochrome bc1 complex
C Hunte et al.
FEBS LETTERS (2003)
The biochemical mode of action of the novel selective fungicide cyazofamid:: Specific inhibition of mitochondrial complex III in Phythium spinosum
S Mitani et al.
PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY (2001)
Structure at 2.3 Å resolution of the cytochrome bc1 complex from the yeast Saccharomyces cerevisiae co-crystallized with an antibody Fv fragment
C Hunte et al.
STRUCTURE (2000)
Share Paper
